Effects of Fascial Plan Blocks on Pulmonary Functions
Effects of External Oblique Fascial Plan Block and Subcostal Transversus Abdominis Plan Block on Postoperative Pulmonary Functions
1 other identifier
observational
1
1 country
1
Brief Summary
In addition to the traumatic effect of the operation, the effort to immobilize the auxiliary respiratory muscles due to pain causes a decrease in postoperative respiratory function (especially in thoracic and upper abdominal surgeries). In addition, superficial and tachypneic breathing caused by the inability of the patient to take deep breaths with pain leads to closure of small airways and increase in intrapulmonary shunts, resulting in hypoxia. Postoperative pain management is important not only to prevent pain but also to reduce pulmonary complications that may occur due to changes in lung function and to reduce mortality and morbidity by controlling the stress response. Pain after nausea and vomiting is the most common reason for hospitalization after laparoscopic surgery. Although pain in laparoscopic cholecystectomy (LC) has many components including incisional, visceral and reflected, the primary source of pain is incisional pain. A multimodal analgesic approach (NSAII, paracetamol, opioids, local infiltration, facial plane blocks and paravertebral and periparavertebral blocks) is recommended. Regional anesthesia combined with general anesthesia reduces the stress response associated with surgery and reduces the need for opioid use. Subcostal TAP Block; injection of local anesthetic between the internal oblique and transversus abdominis muscles in the upper quadrant of the anterior abdominal wall blocks the anterior cutaneous branches of the thoracoabdominal nerves. External Oblique Fascial Plane Block (EOIB); blocks both the anterior and lateral cutaneous branches of the thoracoabdominal nerves. It is performed between the 6th-7th costae. There is a cutaneous sensory block between T6-T9 in the midabdomen and T6-T10 in the anterior axillary line. The conventional method is the administration of intravenous opioids as a method of postoperative analgesia when the routine block cannot be performed due to a contraindication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2023
CompletedFirst Posted
Study publicly available on registry
November 22, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMay 28, 2025
May 1, 2025
11 months
November 16, 2023
May 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the effect of plane blocks on postoperative pulmonary function
The effect of pain relief after plane blocks on postoperative pulmonary function
during the postoperative 24 hours
Secondary Outcomes (3)
opioid consumption
during the postoperative 24 hours
Incidence of nausea and vomiting
during the postoperative 24 hours
quality of recovery-15
during the postoperative 24 hours
Study Arms (3)
External Oblique Fascial Plan Block
Subcostal Transversus Abdominis Plan Block
Control
Interventions
injection of local anesthetic to the myofascial plane
Eligibility Criteria
Patients who will undergo cholecystectomy between the ages of 18-65
You may qualify if:
- years old
- ASA I-II-III risk group
- Patients whose consent was obtained with an informed consent form
- She will undergo a cholecystectomy operation
- Patients to be cooperative for SFT test
You may not qualify if:
- \<18 years and \>65 years
- ASA ≥ IV
- Pulmonary function test below 50% of the expected value
- Known diaphragm paralysis
- Body mass index \>30
- Myocardial infarction within 1 month
- Dementia or confusion
- Lack of cooperation
- People with respiratory diseases
- Congestive heart failure
- Unstable hypertension
- Thoracoabdominal surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zonguldak Bülent Ecevit University Faculty of Medicine
Kozlu, Zonguldak Province, 67600, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 16, 2023
First Posted
November 22, 2023
Study Start
December 1, 2023
Primary Completion
October 30, 2024
Study Completion
December 31, 2024
Last Updated
May 28, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share